SAMLYN CAPITAL, LLC

Holdings History for Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

Symbol: INZY
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

Samlyn Capital, LLC ownership in Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY)

14 Feb 2025 - Samlyn Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY). This represents 0% ownership of the company. This is the first filing by SAMLYN CAPITAL, LLC disclosing ownership of Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Samlyn Capital, LLC	0%		$0	0			$1.06	13G/A	31 Dec 2024	14 Feb 2025, 13:59

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2024		-0.28%	$0	0	-3,259,158	-100%	$4.00	Q4 2024
30 Sep 2024	0.28%	-0.01%	$17,045,397	3,259,158	-91,377	-2.7%	$5.23	Q3 2024
30 Jun 2024	0.26%	+0.03%	$14,943,385	3,350,535	+437,622	+15%	$4.46	Q2 2024
31 Mar 2024	0.39%	-0.06%	$22,312,915	2,912,913	-459,645	-14%	$7.66	Q1 2024
31 Dec 2023	0.31%	+0.01%	$14,367,097	3,372,558	+127,350	+3.9%	$4.26	Q4 2023
30 Sep 2023	0.24%	+0.24%	$13,629,873	3,245,208	+3,245,208	NEW	$4.20	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.